Post has shared content

Post has shared content

Post has shared content
Gut bacteria may play a role in Alzheimer’s disease
New research from Lund University in Sweden has shown that intestinal bacteria can accelerate the development of Alzheimer’s disease. According to the researchers behind the study, the results open up the door to new opportunities for preventing and treating the disease.

Because our gut bacteria have a major impact on how we feel through the interaction between the immune system, the intestinal mucosa and our diet, the composition of the gut microbiota is of great interest to research on diseases such as Alzheimer’s. Exactly how our gut microbiota composition is composed depends on which bacteria we receive at birth, our genes and our diet.

By studying both healthy and diseased mice, the researchers found that mice suffering from Alzheimer’s have a different composition of gut bacteria compared to mice that are healthy. The researchers also studied Alzheimer’s disease in mice that completely lacked bacteria to further test the relationship between intestinal bacteria and the disease. Mice without bacteria had a significantly smaller amount of beta-amyloid plaque in the brain. Beta-amyloid plaques are the lumps that form at the nerve fibres in cases of Alzheimer’s disease.

To clarify the link between intestinal flora and the occurrence of the disease, the researchers transferred intestinal bacteria from diseased mice to germ-free mice, and discovered that the mice developed more beta-amyloid plaques in the brain compared to if they had received bacteria from healthy mice.

Source and further reading:
http://www.lunduniversity.lu.se/article/gut-bacteria-may-play-a-role-in-alzheimers-disease

Article:
https://www.nature.com/articles/srep41802

Infographic via The Huffington Post

#neurobiology #neuroscience #research #gutbacteria 
Photo

Post has attachment
HuScL-1(R), HuScL-2(R), HuScL-3(R) and HuScL-4(R) Human Single Chain (scFv) Antibody Libraries are natural or synthetic libraries of a diversity of over 2.0×109. Recently, we have created a next-generation, fully-human, yeast display scFv library - HuScL-YDP. We also have a HuFabL(R) Human Fab Antibody Library of a size of 2.0×109. Besides human antibody libraries, we have a MuScL(R) Murine Single Chain Antibody Library and a MuFabL(R) Murine Fab Antibody Library. http://www.creative-biolabs.com/premade-human-and-mouse-antibody-libraries.html


To overcome the current drawback of sequencing based on traditional methods, Creative Biolabs has developed the proprietary Database Assisted Shotgun Sequencing (DASS) technology, which based on our next generation antibody sequencing platform. Our services consist of variable region, variable plus leader region and full length heavy- and light-chain antibody sequencing for all species, isotypes and allotypes.http://www.creative-biolabs.com/next-generation-antibody-sequencing.html. Creative Biolabs. marketing@creative-biolabs.com.


Post has attachment
SIRE Life Sciences® is a recruitment and executive search consultancy, dedicated exclusively to the European Life Science industry. SIRE Life Sciences® provides a Complete Life Science Cycle Search Solution to both Life Science Professionals and Life Science Employers operating in the European Life Science Sector. We provide a tailor made European wide service for both permanent and freelance solutions, specialized in delivering to the worlds leading Life Science institutions. Visit our website!: https://sire-search.com/ 
Wait while more posts are being loaded